Screening for diabetic retinopathy and diabetic macular edema in the united kingdom

Current Diabetes Reports

Volumn 12, Issue 4, 2012, Pages 338-345

  Peto, Tunde ^a   Tadros, Christine ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Diabetic macular edema; Diabetic retinopathy; Prevention; Screening; Visual loss

Indexed keywords

ARTICLE; BLINDNESS; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE SEVERITY; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; EYE CARE; HEALTH CARE QUALITY; HUMAN; MASS SCREENING; OUTCOME ASSESSMENT; PATIENT SAFETY; QUALITY OF LIFE; SOCIAL WELFARE; UNITED KINGDOM; VISUAL ACUITY; VISUAL FIELD;

ADULT; AGED; BLINDNESS; COST-BENEFIT ANALYSIS; DIABETIC RETINOPATHY; EARLY DIAGNOSIS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GREAT BRITAIN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; SOCIAL CLASS;

EID: 84865584620     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-012-0285-4     Document Type: Article

References (58)

1. Duh E, Chung N, Wong T. Diabetic retinopathy and systemic complications. In: Duh E, editor. Diabetic retinopathy. New Jersey: Humana Press; 2009. p. 465-82.
2. Cheung N, Mitchell P, Wong T. Diabetic Retinopathy. Lancet. 2010;376:124-36.
3. NHS Centre for Reviews and Dissemination (NHS CRD). Complications of diabetes: Screening for retinopathy, management of foot ulcers. E Health Care. 1999;5:1-12. Available at http://www.york.ac.uk/inst/crd/EHC/ehc54.pdf
4. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;98:823-33.
5. Tanner V. Diabetic retinopathy. In: Kanski JJ, editor Clinical ophthalmology -a systematic approach. Philadelphia: Elsevier, 2007; 573.
6. Wright AD, Dodson PM. Medical management of diabetic retinopathy: Fenofibrate and accord eye studies. Eye. 2011;25:843-9.
7. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-85.
8. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin dependent diabetes mellitus. the Diabetes Control and Complication Trial. Arch Ophthalmol 1995;113:36-51
9. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular oedema (RESOLVE Study): A 12-month, randomized, controlled, double masked multicentre phase II study. Diabetes Care. 2010;33:2399-405.
10. Mitchell P, Bandello F, Schmidt-Ehrfurt U, et al. The RESTORE study: Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular oedema. Ophthalmology. 2011;118:615-25.
11. Diabetic Retinopathy Clinical Research Network. Randomised clinical trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic maculae oedema. Ophthalmology. 2010;117:1064-77.
12. Michaelides M, Kaines A, Hamilton RD, et al. A prospective randomised trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular oedema. (BOLT Study) 12 months data: Report 2. Ophthalmology. 2010;117:1078-86.
13. NHS Diabetic Eye Screening Programme, at http: / / diabeticeye.screening. nhs.uk
14. City and Guild Diabetic Retinopathy Screening Level 3 qualification http://www.cityandguilds.com/46827.html
15. The "Test and Training Set" www.drseqa.org
16. Stefansson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand. 2000;78:374-85. (Pubitemid 30609364)
17. Scanlon PH. The English National screening programme for sightthreatening diabetic retinopathy. J Med Screen. 2008;15(1):1-4. (Pubitemid 351629537)
18. Arora S, Kolb S, Goyder E, McKibbin MM. Trends in the incidence of visual impairment resulting from diabetic retinopathy in the Leeds metropolitan area, 2005-2010. Diabet Med. 2012 Feb 22. [Epub ahead of print].
19. The Information Centre for Health and Social Care: Registered Blind and Partially sighted people -Year ending 31 March 2011, in England. http://www.ic.nhs.uk/statistics-and-data-collections/social-care/ adult-social-care-information/registered-blind-and-partially-sightedpeople-year- ending-31-march-2011-in-england
20. Klein R, Klein BEK. Are individuals with diabetes seeing better? A long-term epidemiological perspective. Diabetes. 2010;59 (8):1853-60. This paper is of importance as it is a good review of major studies that examine the relationship between diabetic retinopathy and systemic risk factors.
21. Ahola AJ, Saraheimo M, Forsblom C, et al; FinnDiane Study Group. Health-related quality of life in patients with type 1 diabetes -association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant. 2010;25(6):1903-8.
22. Davidov E, Breitscheidel L, Clouth J, et al. Diabetic retinopathy and health-related quality of life. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):267-72.
23. Gabrielian A, Hariprasad SM, Jager RD, et al. The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life. Eye. 2010;124:29-35.
24. Hariprasad SM, Mieler WF, Grassi JL, et al. Vision-related quality of life in patients with diabetic macular edema. Br J Ophthalmol. 2008;92(1):89-92.
25. Zoega GM, Gunnarsdottir T, Bjornsdottir S, et al. Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand. 2005;83(6):687-90. (Pubitemid 41823816)
26. Yeo ST, Edwards RT, Fargher EA, et al. Preferences of people with diabetes for diabetic retinopathy screening: A discrete choice experiment. Diabet Med. 2012 March13. [Epub ahead of print].
27. Royal College of Ophthalmologists: Section 5 Screening for diabetic retinopathy. Available at http://www.rcophth.ac.uk
28. Crijns H, Hendrikse F. Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy. Int J Technol Assess Health Care. 1999;15:0198-206.
29. Polak BC, Crijns H, Casparie AF, Niessen LW. Cost-effectiveness of glycaemic control and ophthalmological care in diabetic retinopathy. Health Policy. 2003;64:89-97. (Pubitemid 36315765)
30. James M, Turner DA, Broadbent DM, et al. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. Br Med J. 2000;320:1627-31. (Pubitemid 30364631)
31. Facey K, Cummins E, Macpherson K, et al. Health technology assessment report 1: Organization of services for diabetic retinopathy screening. Available at http://www.ndrs.scot.nhs.uk/Links/ Docs/hta1.pdf
32. Scott IU, Edwards AR, Aiello LP, et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. diabetic retinopathy clinical research network. Ophthalmol. 2007;114:1860-7.
33. Beck RW, Edwards AR, Aiello LP, et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Diabetic Retinopathy Clinical Research Network (DRCR.net). Arch Ophthalmol. 2009;127:245-51.
34. Aiello LP, Edwards AR, Beck RW, et al. Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. Diabetic retinopathy clinical research network. Ophthalmol. 2010;117:946-53.
35. Glassman AR, Beck RW, Brownning DJ, et al. Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials prospective. Diabetic Retinopathy Clinical Research Network Study Group. Invest Ophthalmol Vis Sci. 2009;50:560-6.
36. Mackenzie S, Schmermer C, et al. SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme. PLoS one 2011;6(5);e14811. This abstract combines the assessment of new technology with assessment of a new pathway and is conducted in a clinic setting .
37. Virgili G, Menchini F, Dimastogiovanni AF, et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: A systematic review. Invest Ophthalmol Vis Sci. 2007;49:2627-34.
38. Noble J, Silva PS, Cavallerano JD, et al. Comparison of nonmydriatic optos® fundus imaging with mydriatic Early Treatment Diabetic Retinopathy Study (ETDRS) 7-Standard field stereo photography and clinical grading. ARVO 2011:Abstract 1283. This abstract shows an excellent example of a well-conducted validation study for new technology.
39. Goatman K, Charnley A, Webster L and Nussey S. Assessment of automated disease detection in diabetic retinopathy screening using two-field photography. PLOS one 2011;6(12) This paper opens up a new avenue on automated grading.
40. Stefansson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophth Scand. 2000;78:374-85. (Pubitemid 30609364)
41. Thomas RL, Dunstan F, Luzio SD, et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the diabetic retinopathy screening services for wales: Retrospective analysis. BMJ. 2012;344:e874.
42. Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sightthreatening retinopathy in patients with type 2 diabetes in the liverpool diabetic eye study: A cohort study. Lancet. 2003;361:195-200. (Pubitemid 36126218)
43. Olafsdottir E, Stefansson E. Biennial eye screening in patients with diabetes without retinopathy; 10-year experience. Br J Ophthalmol. 2008;91:1599-601. (Pubitemid 350207380)
44. Kohner EM, Stratton IM, Aldington SJ, et al. Relationship between the severity of retinopathy and progression to photocoagulation in patients with type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med. 2001;18:178-84. (Pubitemid 32397854)
45. Vijan S, Hofer T, Hayward R. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000;283:889-96. (Pubitemid 30102129)
46. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105:1801-15. (Pubitemid 28509717)
47. Lyons TJ, Jenkins AJ, Zheng D, et al. Diabetic retinopathy and serum lipoprotein substances in the DCCT/EDIC cohort. IOVS. 2004;45:910-8. (Pubitemid 38868391)
48. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of microvascular and macrovascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-13.
49. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: Risk factors for incidence and progression of diabetic retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44:256-163.
50. Kristinsson JK. Diabetic retinopathy screening and prevention of blindness. A doctoral thesis. Acta Ophthalmol Scand Suppl. 1997;223:1-76.
51. Aspelund T, Porisdottir O, Olafsdottir E, Gudmundsdottir A, Einarsdottir AB, et al. Individual risk assessment and information technology to optimize screening frequency for diabetic retinopathy. Diabetologia. 2011;54:2525-32.
52. Jones S, Edwards T. Diabetic retinopathy screening: A systematic review of the economic evidence. Diabet Med. 2010;27:249-56.
53. Sivaprasad S, Gupta B, Gulliford M, Dodhia H, Mohamed M et al. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PloS One. 2012; 7(3):e32182. This paper is of importance to those who work in ethnically diverse communities.
54. Klein R, Sharrett AR, Klein BE, Moss SE, Folsom AR, et al. The association of atherosclerosis, vascular risk factors and retinopathy in adults with diabetes: The atherosclerosis risk in communities study. Ophthalmology. 2002;109:1225-34. (Pubitemid 34700911)
55. Wong TY, Klein R, Islam FM, Cotch MF, Folsom AR, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141:446-55.
56. McGeechan K, Liew G, Macaskill P, et al. Prediction of incident stroke events based on retinal vessel caliber: A systematic review and individual-participant meta-analysis. Am J Epidemiol. 2009;170 (11):1323-32. This paper is of importance as it is a well-conducted meta-analysis and contains all seminal papers in this field.
57. Ong HS, Levin S, Vafidis G. Glaucoma detection using optic disc images from the English National Screening Programme for diabetic retinopathy. J Glaucoma 2012 Jan 20. [Epub ahead of print]. This paper can potentially influence how the screening imaging might be used for glaucoma screening as well.
58. Hadley G, Earnshaw JJ, Stratton I, Sykes J, Scanlon PH. A potential pathway for managing diabetic patients with arterial emboli detected by retinal screening. Eur J Vasc Endovasc Surg. 2011;42(2):153-57. This paper is of importance as it shows how screening might influence patient pathway.